Central South University

This study looks at whether the diabetes drug metformin can prevent blood sugar issues caused by statins (cholesterol-lowering drugs) in people with schizophrenia. About 400 adults with stable schizophrenia will take either metformin or a placebo alongside a statin for six months…

This study is testing whether metformin, a drug typically used for diabetes, can improve cognitive problems like memory and attention in people with schizophrenia. Researchers will give 120 participants either metformin or a placebo for 24 weeks and measure changes in thinking sk…

This study tests whether a non-invasive brain stimulation technique called navigated transcranial magnetic stimulation (nTMS) can reduce negative symptoms of schizophrenia, such as lack of motivation, social withdrawal, and reduced speech. Forty adults with schizophrenia will rec…

This study looks at 500 people with a rare type of lung cancer that has air-filled cysts. Researchers want to find the best way to measure the tumor size to improve staging and predict outcomes. They will also use AI to analyze CT scans and see how imaging features relate to the …

This study looks at 300 people with early-stage lung cancer to understand why some tumors grow differently. Researchers will analyze genes, immune cells, and other markers from tumor samples. The goal is to find patterns that could lead to better predictions of cancer return and …

This study uses artificial intelligence to analyze patient data—like scans, lab results, and medical history—to predict how well esophageal cancer responds to chemotherapy and immunotherapy before surgery. Researchers aim to identify which patients achieve a complete response and…